Dr. Hinestrosa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1707 N Mills Ave
Orlando, FL 32803Phone+1 407-647-3960Fax+1 407-413-5775
Education & Training
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Infectious Disease, 2007 - 2009
Geisinger Health System (Danville)Residency, Internal Medicine, 2004 - 2007
Universidad CESClass of 1997
Certifications & Licensure
FL State Medical License 2009 - 2025
DC State Medical License 2007 - 2010
PA State Medical License 2004 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2014
Clinical Trials
- Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects Start of enrollment: 2017 Apr 20
Publications & Presentations
PubMed
- 62 citationsSofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen.Edward Gane, Mitchell L. Shiffman, Kyle Etzkorn, Giuseppe Morelli, Catherine A.M. Stedman
Hepatology. 2017-10-01 - 8 citationsVirologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced,...Charlotte-Paige Rolle, Vu Nguyen, Federico Hinestrosa, Edwin DeJesus
AIDS Research and Therapy. 2021-05-03 - 42 citationsEfficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 TrialEric Lawitz, Nancy Reau, Federico Hinestrosa, Mordechai Rabinovitz, Eugene R. Schiff
Gastroenterology. 2016-11-01
Press Mentions
Treatment-Related Early Discontinuations and Adverse Events Among Newly Diagnosed People Living with HIV Initiating Integrase Inhibitors in a Real-World SettingFebruary 1st, 2023- Finest Doctors of 2020: A Unique CallingDecember 4th, 2020
- Finest Doctors of 2020: The Mysteries of COVID-19December 3rd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
